Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Añadir filtros








Intervalo de año
1.
China Journal of Chinese Materia Medica ; (24): 2679-2698, 2023.
Artículo en Chino | WPRIM | ID: wpr-981372

RESUMEN

Cytisine derivatives are a group of alkaloids containing the structural core of cytisine, which are mainly distributed in Fabaceae plants with a wide range of pharmacological activities, such as resisting inflammation, tumors, and viruses, and affecting the central nervous system. At present, a total of 193 natural cytisine and its derivatives have been reported, all of which are derived from L-lysine. In this study, natural cytisine derivatives were classified into eight types, namely cytisine type, sparteine type, albine type, angustifoline type, camoensidine type, cytisine-like type, tsukushinamine type, and lupanacosmine type. This study reviewed the research progress on the structures, plant sources, biosynthesis, and pharmacological activities of alkaloids of various types.


Asunto(s)
Alcaloides/química , Quinolizinas/farmacología , Azocinas/química , Fabaceae
2.
Acta cir. bras ; 33(11): 945-953, Nov. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-973475

RESUMEN

Abstract Purpose: To investigate the effect of oxymatrine on periodontitis in rats and related mechanism. Methods: Ninety SD rats were divided into control, model, 10, 20 and 40 mg/kg oxymatrine and tinidazole groups. The periodontitis model was established in later 5 groups. The 10, 20 and 40 mg/kg oxymatrine groups were intragastrically administrated with 10, 20 and 40 mg/kg oxymatrine, respectively. The tinidazole group was intragastrically administrated with 100 mg/kg tinidazole. The treatment duration was 4 weeks. The tooth mobility, gingival and plaque indexes, serum inflammatory factor levels and gingival tissue matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) protein levels were detected. Results: After treatment, compared with model group, in 40 mg/kg oxymatrine group the rat general conditions were obviously improved, the tooth mobility, gingival index and plaque index were significantly decreased (P<0.05), the serum tumor necrosis factor-α, interleukin-1β and prostaglandin E2 levels were significantly decreased (P<0.05), the MMP-2 and MMP-9 protein levels were significantly decreased (P<0.05), and the TIMP-2 protein level was significantly increased (P<0.05). Conclusions: Oxymatrine can alleviate the experimental periodontitis in rats. The mechanism may be related to its inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression.


Asunto(s)
Animales , Masculino , Femenino , Periodontitis/tratamiento farmacológico , Quinolizinas/farmacología , Inhibidores Tisulares de Metaloproteinasas/efectos de los fármacos , Metaloproteinasas de la Matriz/efectos de los fármacos , Alcaloides/farmacología , Antiinflamatorios/farmacología , Periodontitis/metabolismo , Valores de Referencia , Tinidazol , Dinoprostona/sangre , Distribución Aleatoria , Índice de Placa Dental , Reproducibilidad de los Resultados , Factor de Necrosis Tumoral alfa/sangre , Resultado del Tratamiento , Ratas Sprague-Dawley , Inhibidores Tisulares de Metaloproteinasas/análisis , Metaloproteinasas de la Matriz/análisis , Interleucina-1beta/sangre , Encía/patología
3.
Acta cir. bras ; 33(3): 207-215, Mar. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-886274

RESUMEN

Abstract Purpose: To investigate whether oxymatrine (OMT) prevents hepatic fibrosis in rats by regulating liver transforming growth factor β1 (TGF-β1) level. Methods: Hepatic fibrosis was induced in rats by thioacetamide (TAA). Blood was collected at the end of week 12 to determine the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and glutathione (GSH). Changes in liver tissue were observed after hematoxylin-eosin (HE) staining. Results: Fibrosis was confirmed by Masson's collagen staining. Liver TGF-β1 level was determined by ELISA. OMT significantly reduced serum ALT and AST but increased GSH levels in rats with hepatic fibrosis. Moreover, it significantly improved liver histology in rats with TAA-induced hepatic fibrosis. It significantly decreased liver TGF-β1 level compared to that in the untreated group. It also significantly reduced collagen deposition in rats. Conclusion: Oxymatrine is effective in protecting rats from thioacetamide-induced hepatic fibrosis by regulating TGF-β1 expression.


Asunto(s)
Animales , Masculino , Ratas , Quinolizinas/farmacología , Sustancias Protectoras/farmacología , Alcaloides/farmacología , Factor de Crecimiento Transformador beta1/metabolismo , Cirrosis Hepática Experimental/prevención & control , Aspartato Aminotransferasas/sangre , Ratas Sprague-Dawley , Factor de Crecimiento Transformador beta1/efectos de los fármacos , Cirrosis Hepática Experimental/inducido químicamente , Cirrosis Hepática Experimental/metabolismo
4.
Acta cir. bras ; 30(6): 422-429, 06/2015. graf
Artículo en Inglés | LILACS | ID: lil-749647

RESUMEN

PURPOSE: To investigate if oxymatrine pretreatment could ameliorate renal I/R injury induced in rats and explore the possible role of oxymatrine in Nrf2/HO-1 pathway. METHODS: Unilaterally nephrectomized rats were insulted by I/R in their left kidney. Twenty four rats were randomly divided into three groups: sham group, I/R + saline-treated group, I/R + OMT-treated group. Oxymatrine or vehicle solution was administered intraperitoneally injected 60 min before renal ischemia, respectively. Renal function, histology, makers of oxidative stress, cell apoptosis and Nrf2/HO-1 expressions were assessed. RESULTS: Oxymatrine pretreatment exhibited an improved renal functional recovery, alleviated histological injury and oxidative stress, inhibiting tubular apoptosis, and accompanied by upregulated the expression of Nrf2/HO-1 proteins. CONCLUSION: Oxymatrine may attenuate renal ischemia/reperfusion injury, and this renoprotective effect may be through activating the Nrf2/HO-1 pathway. .


Asunto(s)
Animales , Masculino , Alcaloides/farmacología , Antioxidantes/farmacología , Hemo-Oxigenasa 1/metabolismo , Riñón/irrigación sanguínea , /metabolismo , Estrés Oxidativo/efectos de los fármacos , Quinolizinas/farmacología , Daño por Reperfusión/prevención & control , Alcaloides/uso terapéutico , Antioxidantes/uso terapéutico , Apoptosis/efectos de los fármacos , Western Blotting , Modelos Animales de Enfermedad , Hemo-Oxigenasa 1/análisis , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Riñón/patología , /análisis , Quinolizinas/uso terapéutico , Distribución Aleatoria , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA